T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Repare Therapeutics
RPTX
$75.6M
| $29.7M | ﹤0.01% |
2,088,345
-78,477
| -4% | -$1.12M |
|
1127
Cincinnati Financial
CINF
$24.6B
| $29.1M | ﹤0.01% |
213,681
-14,748
| -6% | -$2.01M |
|
|
BCPC
1128
Balchem Corporation
BCPC
$5.1B
| $29M | ﹤0.01% |
212,375
+59,224
| +39% | +$8.1M |
|
1129
Ameresco
AMRC
$1.46B
| $28.9M | ﹤0.01% |
363,857
+5,829
| +2% | +$463K |
|
1130
Ingevity
NGVT
$2.13B
| $28.9M | ﹤0.01% |
450,912
-33,495
| -7% | -$2.15M |
|
1131
Pacira BioSciences
PCRX
$1.21B
| $28.8M | ﹤0.01% |
377,765
+2,304
| +0.6% | +$176K |
|
1132
Five Star Bancorp
FSBC
$705M
| $28.8M | ﹤0.01% |
1,017,272
+12,675
| +1% | +$359K |
|
1133
Best Buy
BBY
$16.1B
| $28.7M | ﹤0.01% |
315,826
-19,113
| -6% | -$1.74M |
|
1134
Kimbell Royalty Partners
KRP
$1.26B
| $28.6M | ﹤0.01% |
1,755,915
-444,770
| -20% | -$7.23M |
|
1135
Sapiens International
SPNS
$2.4B
| $28.5M | ﹤0.01% |
1,123,376
+15,463
| +1% | +$393K |
|
1136
Omnicom Group
OMC
$14.8B
| $28.4M | ﹤0.01% |
334,745
-21,715
| -6% | -$1.84M |
|
1137
Krispy Kreme
DNUT
$536M
| $28.3M | ﹤0.01% |
+1,905,850
| New | +$28.3M |
|
1138
Axcelis
ACLS
$2.69B
| $28.1M | ﹤0.01% |
+371,381
| New | +$28.1M |
|
1139
Lyell Immunopharma
LYEL
$252M
| $27.7M | ﹤0.01% |
274,696
+17,631
| +7% | +$1.78M |
|
1140
Ranpak Holdings
PACK
$398M
| $27.7M | ﹤0.01% |
1,357,587
+3,886
| +0.3% | +$79.4K |
|
1141
Roku
ROKU
$13.7B
| $27.5M | ﹤0.01% |
219,763
-974,877
| -82% | -$122M |
|
1142
Teladoc Health
TDOC
$1.36B
| $27.4M | ﹤0.01% |
380,081
+18,182
| +5% | +$1.31M |
|
1143
Wabtec
WAB
$32.5B
| $27.4M | ﹤0.01% |
284,593
-7,791
| -3% | -$749K |
|
1144
Synchrony
SYF
$28.1B
| $27.3M | ﹤0.01% |
785,355
-43,208
| -5% | -$1.5M |
|
1145
Moog
MOG.A
$6.28B
| $27.3M | ﹤0.01% |
310,453
-57,414
| -16% | -$5.04M |
|
1146
Provident Bancorp
PVBC
$226M
| $27.2M | ﹤0.01% |
1,677,586
+300
| +0% | +$4.87K |
|
1147
H.B. Fuller
FUL
$3.35B
| $27.1M | ﹤0.01% |
410,673
+22,304
| +6% | +$1.47M |
|
1148
CareDx
CDNA
$723M
| $27.1M | ﹤0.01% |
732,182
-116,631
| -14% | -$4.31M |
|
1149
Alector
ALEC
$286M
| $26.9M | ﹤0.01% |
1,890,908
+14,060
| +0.7% | +$200K |
|
|
MRO
1150
DELISTED
Marathon Oil Corporation
MRO
| $26.9M | ﹤0.01% |
1,071,057
-31,347
| -3% | -$787K |
|